The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.

Avery E BraunJune M ChanJohn NeuhausJanet E CowanStacey A KenfieldErin L Van BlariganImelda TenggaraJeanette M BroeringJeffry P SimkoPeter R CarrollMatthew R Cooperberg

Published in: Cancer (2024)

GCs did not substantially improve a clinical prediction model for UG/US, a short-term and imperfect surrogate for clinically relevant disease outcomes.

Keyphrases

prostate cancer
radical prostatectomy
gene expression
metabolic syndrome
adipose tissue
weight loss
genome wide
glycemic control